DK0833820T3 - Benzisoxazol- og indazolderivater som antipsykotiske midler - Google Patents

Benzisoxazol- og indazolderivater som antipsykotiske midler

Info

Publication number
DK0833820T3
DK0833820T3 DK96915782T DK96915782T DK0833820T3 DK 0833820 T3 DK0833820 T3 DK 0833820T3 DK 96915782 T DK96915782 T DK 96915782T DK 96915782 T DK96915782 T DK 96915782T DK 0833820 T3 DK0833820 T3 DK 0833820T3
Authority
DK
Denmark
Prior art keywords
benzisoxazole
antipsychotic agents
indazole derivatives
indazole
derivatives
Prior art date
Application number
DK96915782T
Other languages
Danish (da)
English (en)
Inventor
Lawrence L Martin
Peter A Nemoto
Mark G Palermo
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0833820T3 publication Critical patent/DK0833820T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK96915782T 1995-06-06 1996-05-14 Benzisoxazol- og indazolderivater som antipsykotiske midler DK0833820T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47040095A 1995-06-06 1995-06-06
PCT/US1996/006851 WO1996039397A1 (fr) 1995-06-06 1996-05-14 Derives de benzisoxazole et d'indazole utilises comme agents neuroleptiques

Publications (1)

Publication Number Publication Date
DK0833820T3 true DK0833820T3 (da) 2001-04-17

Family

ID=23867483

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96915782T DK0833820T3 (da) 1995-06-06 1996-05-14 Benzisoxazol- og indazolderivater som antipsykotiske midler

Country Status (20)

Country Link
US (3) US5696113A (fr)
EP (1) EP0833820B1 (fr)
JP (2) JP3057763B2 (fr)
KR (1) KR100304179B1 (fr)
AR (1) AR002300A1 (fr)
AT (1) ATE199147T1 (fr)
AU (1) AU697953B2 (fr)
CA (1) CA2218663C (fr)
DE (1) DE69611783T2 (fr)
DK (1) DK0833820T3 (fr)
ES (1) ES2157442T3 (fr)
GR (1) GR3035663T3 (fr)
HU (1) HUP9802492A3 (fr)
IL (1) IL118530A0 (fr)
MX (1) MX9709451A (fr)
NO (1) NO975681L (fr)
NZ (1) NZ307958A (fr)
PT (1) PT833820E (fr)
WO (2) WO1996039397A1 (fr)
ZA (1) ZA964562B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008348A (en) * 1995-06-06 1999-12-28 Hoechst Marion Roussel, Inc. Antipsychotic agents, compositions and method of use
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
UA72189C2 (uk) 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7125903B1 (en) * 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
GB0117531D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
KR100627031B1 (ko) * 2004-09-04 2006-09-21 주식회사 케이티프리텔 등산 정보 서비스 제공 방법 및 장치
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
KR100673033B1 (ko) * 2005-06-21 2007-01-22 (주) 엘지텔레콤 레저 전용 휴대 단말기
AU2007217040A1 (en) 2006-02-17 2007-08-30 Memory Pharmaceuticals Corporation Compounds having 5-HT6 receptor affinity
CA2737252A1 (fr) * 2008-09-23 2010-04-01 F. Hoffmann-La Roche Ag Derives d'isoxazolo[4,5]pyridin-3-yl-piperazine utiles en tant que modulateurs des recepteurs de dopamine d3
TW201103904A (en) * 2009-06-11 2011-02-01 Hoffmann La Roche Janus kinase inhibitor compounds and methods
CN110117278B (zh) * 2018-02-07 2022-07-19 石家庄以岭药业股份有限公司 烷氧基苯并五元(六元)杂环胺类化合物及其药物用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4670447A (en) * 1983-08-22 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
US4806649A (en) * 1983-08-22 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. 3-(piperidinyl)- and 3- (pyrrolidinyl)-1H-indazoles
US4853470A (en) * 1983-08-22 1989-08-01 Hoechst-Roussel Pharmaceuticals, Inc. 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
MX174210B (es) * 1987-02-17 1994-04-28 Pfizer Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos
EP0302423A3 (fr) * 1987-08-07 1991-01-09 Hoechst-Roussel Pharmaceuticals Incorporated Phényl-1(pipérazinyl-1)-3-indazoles-1H, procédé et intermédiares pour leur préparation, et leur utilisations comme médicaments
NZ233525A (en) * 1989-05-15 1991-09-25 Janssen Pharmaceutica Nv Piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers and pharmaceutical compositions
EP0402644B1 (fr) * 1989-05-19 1995-08-16 Hoechst-Roussel Pharmaceuticals Incorporated N-(aryloxyalkyl)hétéroarylpipéridines et -hétéroarylpipérazines, leur procédé de préparation et leur application comme médicaments
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5077405A (en) * 1989-09-11 1991-12-31 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1-Substituted-4-piperazinyl)-1H-indazoles
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
JP2659107B2 (ja) * 1991-03-28 1997-09-30 エーザイ株式会社 複素環式―環式アミン誘導体
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5206366A (en) * 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds

Also Published As

Publication number Publication date
NO975681D0 (no) 1997-12-05
US5696113A (en) 1997-12-09
NZ307958A (en) 1999-02-25
AU697953B2 (en) 1998-10-22
HUP9802492A2 (hu) 1999-09-28
AR002300A1 (es) 1998-03-11
IL118530A0 (en) 1996-10-16
CA2218663A1 (fr) 1996-12-12
NO975681L (no) 1998-02-05
ATE199147T1 (de) 2001-02-15
KR100304179B1 (ko) 2001-11-22
WO1996039405A1 (fr) 1996-12-12
EP0833820A1 (fr) 1998-04-08
DE69611783D1 (de) 2001-03-22
JPH11506728A (ja) 1999-06-15
KR19990022264A (ko) 1999-03-25
AU5746496A (en) 1996-12-24
GR3035663T3 (en) 2001-06-29
CA2218663C (fr) 2001-07-31
MX9709451A (es) 1998-02-28
ES2157442T3 (es) 2001-08-16
EP0833820B1 (fr) 2001-02-14
US5852022A (en) 1998-12-22
JP3122469B2 (ja) 2001-01-09
PT833820E (pt) 2001-07-31
HUP9802492A3 (en) 1999-10-28
JPH11507030A (ja) 1999-06-22
ZA964562B (en) 1996-12-12
US5965554A (en) 1999-10-12
DE69611783T2 (de) 2001-09-20
JP3057763B2 (ja) 2000-07-04
WO1996039397A1 (fr) 1996-12-12

Similar Documents

Publication Publication Date Title
FI970310A (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
DE69611361D1 (de) Chinazolin-derivate
NO974103L (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698D1 (de) Chinazolin-derivate
NO307954B1 (no) Orale flytende preparater inneholdende paroxetin-resinat
DK0832061T3 (da) Benzamidderivater og anvendelse deraf som vasopressin-antagonister
DE69621528D1 (de) Anti-inflamatorische agenzien
KR970707039A (ko) 알루미노-실리케이트 유도체(alumino-silicate derivatives)
DE59608798D1 (de) Endoparasitizide mittel
BR9709051A (pt) Derivados de indazol substituidos e compostos relacionados
PT778023E (pt) Agentes neuroprotectores
NO984106D0 (no) Azolobenzazepin-derivater som neurologisk aktive midler
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DK0833820T3 (da) Benzisoxazol- og indazolderivater som antipsykotiske midler
DE69520235D1 (de) Schweisshemmende mittel
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
ATA100695A (de) Prothrombin-derivate
NO975880L (no) Formylderivater anvendt som ikke-ioniske kontrastmidler
DE69628200D1 (de) Diarylalkenylamin-derivate
ATE239018T1 (de) Pyrazol-derivate
ATE204255T1 (de) Carbostyrilderivate als antithrombotische mittel
DK0723963T3 (da) 4-Amino-benzoylguanidin-derivater
DK0848713T3 (da) Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som antipsykotiske midler
DE59610106D1 (de) Fluorbenzylether-Derivate